Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Oxytocin for Emotional Processing in Healthy Men
NCT04320706Phase 1Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Feb 2020
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Autism Spectrum Disorder (ASD) and schizophrenia comparing Oral Oxytocin with Oral Placebo (2 arms). Primary endpoints: Neural responses to positive and negative valence emotional faces, Neural responses to positive and negative valence scenes and 2 more. Status: unknown.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)schizophrenia
Beyond the preview
Go deeper on NCT04320706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04320706.